Tuesday, March 29, 2016

Aveo Pharmaceuticals to pay U.S. SEC $4 mln to settle kidney drug case

March 29 (Reuters) - Biotech company Aveo Pharmaceuticals

Inc will pay $4 million to settle civil charges that it

misled investors about U.S. regulators' concerns involving its

drug to treat kidney...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)